International Pediatric Neuro-Oncology Tumor Board

The International Pediatric Neuro-Oncology Tumor Board was established in January 2021 as a monthly multi-disciplinary collaboration, but now includes 38 institutions from 26 countries from all continents.

The tumor board offers binational exchange of resources and expertise, dissemination of knowledge and collaborative research virtually, without the need to travel. We leverage this platform to bring a patient-centered approach to cancer treatment, considering the appropriate level of resources available within their home countries. Complex cases of pediatric brain and spine tumors are presented and discussed at each meeting. These cases may involve newly-diagnosed patients, recurrent tumors, or challenging treatment decisions. Tumor board members review the clinical information, radiological imaging, pathology reports and other relevant data to collectively recommend the best course of action for each patient.

GNOP board cases by type:
NF-related tumors	29%
GCTs	6%
Ependymoma	5%
Other embryonal tumors	10%
Medullablastoma	10%
HGG/DMG/DIPGs	8%
LGGs	21%
Others	11%
GNOP board cases by type

As of September 2023, we have held 28 tumor boards, and discussed 98 cases.

In addition, we actively promote research in the field of pediatric neuro-oncology. By collaborating on research projects and sharing data, this international tumor board aims to advance our understanding of brain and nerve tumors in children and explore novel therapeutic approaches.